Institut Gustave Roussy (IGR), Villejuif, France.
Pediatr Blood Cancer. 2013 Jun;60(6):928-34. doi: 10.1002/pbc.24374. Epub 2013 Jan 9.
To evaluate a strategy whereby extensive surgery ± external radiotherapy (RT) could improve local control in pterygopalatine/infratemporal fossa (PIF) sarcoma.
Forty-one patients with a diagnosis of sarcoma involving the PIF and referred to our Institute from 1984 to 2009 were included in the analysis. Patients received multidrug chemotherapy and radiotherapy ± surgery, depending on the period of treatment.
The median age at diagnosis was 7.6 years (range: 0.1-22 years). There were 36 RMS, 3 undifferentiated sarcoma and 2 other soft-tissue sarcomas. Sixty-eight percent of patients had meningeal risk factors at diagnosis. Local treatment consisted of RT alone in 19 patients, surgery in combination to RT in 19 patients and surgery alone in 3 patients. The local progression rate (LPR) at 5 years was 45% for the entire population, 59% for the 19 patients treated with RT alone and 34% for the 22 patients who had surgery as part of their treatment. All locoregional failures after extensive surgery occurred at the skull base and/or in leptomeningeal spaces.
Multidisciplinary approach including extensive surgery for PIF sarcoma is feasible and yields good local control with 15/22 patients in local complete remission. Future studies are warranted to confirm these promising results, to evaluate the possibility of avoiding RT or limiting the RT field, and to extend the indication for extensive surgery to other "worse" sites of PM sarcoma such as the paranasal sinuses.
评估一种策略,即广泛的手术加外部放疗(RT)是否可以提高翼腭窝/颞下窝(PIF)肉瘤的局部控制率。
分析了 1984 年至 2009 年期间我院收治的 41 例 PIF 肉瘤患者。根据治疗时期,患者接受多药化疗和放疗±手术治疗。
诊断时的中位年龄为 7.6 岁(范围:0.1-22 岁)。36 例 RMS,3 例未分化肉瘤和 2 例其他软组织肉瘤。68%的患者在诊断时存在脑膜危险因素。19 例患者单独接受 RT 治疗,19 例患者接受 RT 联合手术治疗,3 例患者单独接受手术治疗。全组患者 5 年局部进展率(LPR)为 45%,单纯 RT 治疗的 19 例患者为 59%,接受手术治疗的 22 例患者为 34%。广泛手术后的所有局部复发病例均发生在颅底和/或软脑膜间隙。
包括广泛手术在内的多学科方法治疗 PIF 肉瘤是可行的,可获得良好的局部控制率,15/22 例患者局部完全缓解。未来的研究需要证实这些有希望的结果,评估是否可以避免 RT 或限制 RT 范围,并将广泛手术的适应证扩展到其他“更差”的 PM 肉瘤部位,如鼻窦。